GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-024929 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 11, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
62,754
Total Value
$144,574.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 9, 2026 | Exercise/Conversion | 14,500 | $0.75 | $10,875.00 | 714,500 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 9, 2026 | Sale | 14,500 | $6.14 | $89,030.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 10, 2026 | Exercise/Conversion | 6,418 | $0.75 | $4,813.50 | 706,418 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 10, 2026 | Sale | 6,418 | $6.21 | $39,855.78 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 9, 2026 | Exercise/Conversion | 14,500 | $0.00 | $0.00 | 847,919 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 10, 2026 | Exercise/Conversion | 6,418 | $0.00 | $0.00 | 841,501 | Direct | โ | View Details |